SHAREHOLDER ALERT: Weiss Law Reminds USER, CLR, AKUS, and LFG Shareholders About Its Ongoing Investigations

NEW YORK, Nov. 15, 2022

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of UserTesting, Inc. (NYSE: USER), in connection with the proposed acquisition of USER by Thoma Bravo and Sunstone Partners.  Under the merger agreement, USER shareholders will receive $7.50 in cash for each share of USER common stock owned.  If you own USER shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/user    

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Continental Resources, Inc. (NYSE: CLR), in connection with the proposed merger of CLR with Omega Acquisition, Inc., via tender offer.  Under the terms of the merger agreement, CLR shareholders will receive $74.28 in cash for each share of CLR common stock owned.  If you own CLR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/clr      

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akouos, Inc. (NASDAQ: AKUS), in connection with the proposed tender offer for AKUS by Eli Lilly and Company.  Under the tender offer, AKUS shareholders will receive $12.50 in cash, plus one contingent value right ("CVR") of up to $3.00 per share for each share of AKUS common stock owned.  If you own AKUS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/akus